Finance

Lists
524164:BOM
IOL Chemicals and Pharmaceuticals Ltd
194,70 INR
-0,21%
(-0,40) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524164...
Open
195,10 INR
High
198,15 INR
Low
191,20 INR
Mkt. cap
57,15 მლრდ.
Avg. vol.
276,60 ათ.
Volume
110,25 ათ.
Dividend
0,62%
Quarterly dividend
0,30 INR
Ex-dividend date
17 თებ. 2026
P/E ratio
34,05
52-wk high
224,00 INR
52-wk low
67,14 INR
EPS
5,72 INR
Shares outstanding
56,21 მლნ.
No. of employees
3 ათ.
Open
195,10 INR
High
198,15 INR
Low
191,20 INR
Mkt. cap
57,15 მლრდ.
Avg. vol.
276,60 ათ.
Volume
110,25 ათ.
Dividend
0,62%
Quarterly dividend
0,30 INR
Ex-dividend date
17 თებ. 2026
P/E ratio
34,05
52-wk high
224,00 INR
52-wk low
67,14 INR
EPS
5,72 INR
Shares outstanding
56,21 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
About IOL Chemicals and Pharmaceuticals Ltd
CEOსანიაი შატურვედი
Employees3,1 ათ.
Founded1986
Headquarters-
SectorPharmaceutical industry
Websiteiolcp.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,68 მლრდ.
5,80 მლრდ.
6,19 მლრდ.
7,56 მლრდ.
Cost of goods sold
3,68 მლრდ.
3,82 მლრდ.
4,02 მლრდ.
4,78 მლრდ.
Cost of revenue
3,68 მლრდ.
3,82 მლრდ.
4,02 მლრდ.
4,78 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
633,50 მლნ.
569,30 მლნ.
719,60 მლნ.
712,10 მლნ.
Operating expense
1,62 მლრდ.
1,61 მლრდ.
1,45 მლრდ.
1,96 მლრდ.
Total operating expenses
5,30 მლრდ.
5,43 მლრდ.
5,46 მლრდ.
6,74 მლრდ.
Operating income
370,90 მლნ.
371,00 მლნ.
729,50 მლნ.
821,50 მლნ.
Other non operating income
68,80 მლნ.
52,90 მლნ.
-209,50 მლნ.
81,80 მლნ.
EBT including unusual items
404,90 მლნ.
275,50 მლნ.
708,10 მლნ.
866,90 მლნ.
EBT excluding unusual items
404,90 მლნ.
387,60 მლნ.
714,60 მლნ.
866,90 მლნ.
Income tax expense
105,20 მლნ.
69,70 მლნ.
176,50 მლნ.
222,90 მლნ.
Effective tax rate
25,98%
25,30%
24,93%
25,71%
Other operating expenses
789,30 მლნ.
837,40 მლნ.
522,90 მლნ.
1,04 მლრდ.
Net income
299,70 მლნ.
205,80 მლნ.
531,60 მლნ.
644,00 მლნ.
Net profit margin
5,28%
3,55%
8,58%
8,52%
Earnings per share
-
-
-
-
Interest and investment income
-
-
149,50 მლნ.
-
Interest expense
-34,80 მლნ.
-36,30 მლნ.
-
-36,40 მლნ.
Net interest expenses
-34,80 მლნ.
-36,30 მლნ.
149,50 მლნ.
-36,40 მლნ.
Depreciation and amortization charges
199,90 მლნ.
201,80 მლნ.
202,90 მლნ.
213,40 მლნ.
EBITDA
569,70 მლნ.
547,28 მლნ.
929,82 მლნ.
1,02 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები